Patients grapple with high cost of arthritis medications

The first American investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief from catastrophic coverage.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1Hg6qmd

No comments:

Post a Comment